Literature DB >> 12091392

Bisindolylmaleimide IX facilitates tumor necrosis factor receptor family-mediated cell death and acts as an inhibitor of transcription.

Oskar W Rokhlin1, Rebecca A Glover, Agshin F Taghiyev, Natalya V Guseva, Richard E B Seftor, Inna Shyshynova, Andrei V Gudkov, Michael B Cohen.   

Abstract

Bisindolylmaleimides (Bis) were originally described as protein kinase C inhibitors. Several studies have shown that Bis potentiate tumor necrosis factor (TNF) receptor family-mediated apoptosis in lymphoid and dendritic cells, but the inhibition of protein kinase C cannot account for these effects (Zhou, T., Song, L., Yang, P., Wang, Z., Lui, D., and Jope, R. S. (1999) Nat. Med. 5, 42-48). We investigated the effect of four Bis derivatives (I, II, VIII, and IX) in human prostatic carcinoma cell lines and found that Bis IX was the most potent inducer of apoptosis under simultaneous treatment with TNF-alpha, agonistic anti-Fas monoclonal antibody, and TNF-related apoptosis-inducing ligand (TRAIL). Bis IX synergistically induced caspase activity in combination with apoptosis-inducing ligands and converted the phenotype of cell lines from apoptosis-resistant to -sensitive. Bis IX induced p53 accumulation in LNCaP (lymph node carcinoma of prostate), which expresses wild-type p53 that was not accompanied by the induction of p53-responsive genes, p21/WAF1, and Mdm2. Moreover, the induction of p21/WAF1 and Mdm2 by doxorubicin was abrogated by simultaneous treatment with Bis IX. These effects apparently result from general inhibition of transcription by Bis IX. We have shown by Northern blot analysis that the transcription activity of the hygromycin gene after transient transfection of pcDNA3.1-Hygro plasmid in 293 and HeLa cells was inhibited by Bis IX in a dose-dependent manner. Moreover, DNA binding activity of Bis IX was prevented by actinomycin D, suggesting that actinomycin D and Bis IX have similar mechanisms of interaction with DNA. In addition, we found that actinomycin D and Bis IX induced caspase activity to the same extent during TRAIL-mediated apoptosis. In summary, these results suggest that Bis IX potentiates TNF receptor family-mediated cell death in part as an inhibitor of transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091392     DOI: 10.1074/jbc.M204612200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP.

Authors:  Oskar W Rokhlin; Agshin F Taghiyev; Natalya V Guseva; Rebecca A Glover; Peter M Chumakov; Julia E Kravchenko; Michael B Cohen
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

2.  Mitochondria-associated apoptotic signalling in denervated rat skeletal muscle.

Authors:  Parco M Siu; Stephen E Alway
Journal:  J Physiol       Date:  2005-03-17       Impact factor: 5.182

3.  Deficiency of the Bax gene attenuates denervation-induced apoptosis.

Authors:  P M Siu; S E Alway
Journal:  Apoptosis       Date:  2006-06       Impact factor: 4.677

4.  Pharmacological targeting of HSP90 with 17-AAG induces apoptosis of myogenic cells through activation of the intrinsic pathway.

Authors:  Akira Wagatsuma; Yuzo Takayama; Takayuki Hoshino; Masataka Shiozuka; Shigeru Yamada; Ryoichi Matsuda; Kunihiko Mabuchi
Journal:  Mol Cell Biochem       Date:  2017-12-16       Impact factor: 3.396

5.  Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubes.

Authors:  Parco M Siu; Yan Wang; Stephen E Alway
Journal:  Life Sci       Date:  2009-02-03       Impact factor: 5.037

6.  The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.

Authors:  Kristine A Drafahl; Christopher W McAndrew; April N Meyer; Martin Haas; Daniel J Donoghue
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

7.  Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder.

Authors:  Xiaosong Bu; Xiaomei Lu; Li Yang; Xiaoyan Xu; Juan Wang; Jiulai Tang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-23       Impact factor: 2.570

8.  Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia.

Authors:  Xin Zhang; Deyong Jia; Junping Ao; Huijuan Liu; Yi Zang; Mohammad Azam; Samy L Habib; Jia Li; Xinsen Ruan; Hao Jia; Xueying Wang; Baojie Li
Journal:  Oncotarget       Date:  2016-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.